Private Equity and Physician Practices: What Physicians Should Negotiate Before Signing with Greg Schaefer

Article

Private Equity and Physician Practices: What Physicians Should Negotiate Before Signing with Greg Schaefer

Greg Schaefer shares insights on private equity's impact on physician practices, key negotiation points for physicians, and preparation strategies for PE deals. He also discusses his Parkinson’s nonprofit initiative.

Private equity has reshaped much of American healthcare over the past decade, and few observers have seen that shift from as many angles as Greg Schaefer.

This transcript of the discussion has been edited for clarity and length.

Mike Sacopulos: My guest today is Greg Schaefer. Mr. Schaefer is the CEO of Schaefer Enterprises, a commercial insurance firm that helps its clients manage risk with proactive strategies. Greg's decades of experience at the national level have given him a macro view of private equity in healthcare. Greg Schaefer, welcome to SoundPractice.

Greg Schaefer: Thank you very much. It is a pleasure to be here.

Sacopulos: The pleasure is all ours. I just gave you the briefest of introductions, but I would like to hear more about your path and what led you to become an expert on private equity. Can you give us a little more background?

Schaefer: Sure. I was born in New York into an insurance agency family; my father started his agency in 1975. In 2010, after I got married and was living in New York City, I decided to start my own agency, Schaefer Enterprises, Inc. I was fortunate enough to marry a dermatologist, and I got involved in the medical space by accident. After we married, she referred to her friends from medical school who had opened practices, and I began insuring a lot of medical practices. As you are aware, over the last 10 years those practices have been getting picked off one by one by private equity, and I have been fortunate enough to be on both sides of the table. In 2019, I sold my agency to private equity, so I have been living through it ever since, and it has been a great experience for me. In 2018, my wife also sold her practice to a private equity–backed dermatology rollup. So it has been part of our lives for many years, and I find it fascinating.

Sacopulos: All doubt has now been removed about whether you are qualified to talk about private equity — you have done it personally, through your wife, and with so many clients. And you are right: Practices are being picked off left and right. Running a national commercial insurance firm, you have watched private equity move aggressively into healthcare over the past decade. For listeners who may not fully understand what's driving this, what makes healthcare such an attractive target for private equity right now? And is the pace accelerating?

Schaefer: I think the pace is steady right now. PE firms are very smart. They look for fragmentation, solid cash flow, and room for operational improvement. Most of the practices they are acquiring at this point are founder-led, often by older physicians who are local, and many have lower insurance reimbursement and have not really scaled yet. Private equity can go in and scale the business, especially with tuck-in acquisitions across the country. They implement HR, better benefits, better technology, and definitely better insurance. So I don't think the pace is accelerating. Interest rates obviously have an effect on that — that is out of my league. But they get better reimbursement rates at a larger scale, and they can turn a small practice into a really nice business.

Sacopulos: Private equity has not entered all specialties evenly, right? Specialties such as dermatology, ophthalmology, orthopedics, and even behavioral health have seen a lot of consolidation and PE involvement, while others remain relatively untouched. What is the calculus behind which specialties get targeted, and what does that mean for physicians practicing in those spaces?

Schaefer: You mentioned a few that really resonate. Dermatology, allergy, dentistry, behavioral health — which is a really popular one right now — and veterinary practices. If you look at the common denominator among many of those, most of the physicians are not going to the hospital. They are not dependent on the hospital. In addition, there are cash-pay components beyond insurance negotiations. So even if insurance companies shrink reimbursements a little, there is still a cash component, which is very attractive to PE.

Sacopulos: What about from the patient's perspective? So often when we talk about private equity, we are talking about either the PE firm or the physicians who are thinking of selling. But what about their patient base? How are patients affected, if at all?

Schaefer: That is a great question. I would say 50% of patients or more don't realize it. They have so much trust in their physician, and I think that is what makes this business so sticky. It is similar to insurance: Once you get a client, they want to deal with you because they trust you. For example, even after my wife and I moved from New York to Florida, people still reached out to her because they trust her. That is the beautiful thing about medicine. You build a patient base, there's trust, and there is not a lot of turnover. As long as the business keeps running smoothly and efficiently after the PE purchase and service is not disrupted, patients stay. I think that is why it is so attractive.

Sacopulos: And presumably that is the goal of the private equity firm — to have things run as smoothly as possible, maybe more smoothly than when the practice was privately held. Would you agree? And what about the argument that founders who sell their practices are hurting their junior colleagues by eliminating the possibility of being self-employed?

Schaefer: The partnership track has definitely changed. Many of the physicians who are getting older are saying, "I'm scared about the risk that private equity is just taking over everything." So I can understand why junior physicians are getting nervous. When private equity comes in, there's definitely disruption, and things change. You are going to change EMRs, and staffing is going to be tight. So there is a concern. Even in medical school, the choice of which specialty you go into is really important these days.

Sacopulos: Whether it is a physician selling a practice or an entrepreneur selling a business, a private equity acquisition has a way of looking very different before and after the closing. What should healthcare practice owners understand about how private equity firms structure these deals?

Schaefer: They need to be careful about the number. The offer number is not always the whole story. They need to understand what life is going to be like after the closing. They need to understand holdbacks, earnouts, performance requirements — and, more important, change, because things are going to change. The new owners will change the EMR very early on. There will be changes in business operations. All these disruptions are going to take you away a bit from what normal was. Understand that the path forward is brighter, but you have to get through some growing pains in the beginning.

Sacopulos: You just used a few terms that some folks in the audience may not know — holdbacks, for example. Can you tell us how some of the pieces of a private equity deal work?

Schaefer: There are a few components to a sale. There is a cash number, and there's equity. To achieve those and deliver on your promise — particularly for practices that are a bit younger than others — the private equity firm might put a holdback on the deal. With a holdback, you need to hit certain performance levels to cash in on those opportunities. A lot of people think things are automatic. We lived through COVID, and that was a scary time. I think holdbacks became much more common after COVID, because some hefty investments had been made and there was no patience. That is when they became really popular.

Sacopulos: If someone in our audience is contemplating a private equity deal as their exit strategy, they may not be able to exit as quickly as they think. When a physician sells his or her practice to private equity, how long after the closing do they typically remain practicing?

Schaefer: It really depends on the age of the physician. For the owners of the practice, the buyer generally wants them to stay on for two to three years. Then there are the junior doctors. If you are a junior doctor and you can embrace the change and the private equity, I think there is a lot of upside and opportunity, especially where there are tuck-ins and the PE firm is trying to grow the practice aggressively. One of the hard points for a junior physician in a practice being purchased is signing a contract that says, "I'm going to stay here for a certain number of years," with a noncompete if they leave. It is very difficult for large practices that sell, because you have to convince your staff and your physicians to believe in the mission and believe that what you are doing is right for the practice. So there are some limitations moving forward, but most of the time I think it turns out well, and people are excited about it.

Sacopulos: Good. What typically surprises sellers most once they are inside this new private equity ownership model?

Schaefer: I say this tongue in cheek, but: control, control, control. You are selling your business. Most people believe the culture is never going to change, and most of the time it does. That is not necessarily a bad thing, but they are going to get a quick lesson in preparing and following budgets, knowing what "below the line" means, and what EBITDA means. You get a really fast lesson in the private equity world post-close.

Sacopulos: Pre-close, what advice do you have for someone who is thinking of moving forward with private equity? How far in advance should they start preparing their practice? What types of professionals do they need? What is a good strategy for getting ready for a private equity deal?

Schaefer: It is a marathon, not a sprint. I would suggest taking the better part of a year to prepare, if not more. The most important thing is to have a great accountant and a great finance team, so you understand your expenses, your revenue, and where everything is coming from. You are going to get a quick lesson in EBITDA, because that is what buyers are looking for. The second thing is a fantastic attorney who can protect you and make sure you understand the components — medical malpractice, buying a tail, who has control over your autonomy as a physician — and, moving forward, the expectations around equity and a liquidity event. If the private equity firm has an event, for example, do you hold preferred shares? Class B shares? Do they have to sell the whole thing? You need support on all of this from a great accountant, a great attorney, and an insurance broker who can explain everything for you post-close.

Sacopulos: This may be a little in the weeds, but you brought up medical malpractice, or professional liability, coverage. I am interested in consent-to-settle provisions. Many providers who are on their own have a policy that says if they are sued, they have a say in whether the case is settled. That may not be true under private equity. What has been your experience, Greg?

Schaefer: That is one of the big pain points for physicians, and it is what makes them very nervous. It goes back to control. The buyers are paying a hefty price for your practice, and they are going to run the business the way they want it to run. One of the first questions we always get from the physicians who work there is: What is going to happen to my insurance? Who is going to pay for my tail? Is it going to be occurrence or claims-made? Giving up that control over consent is very scary. And yes, it happens quite frequently, because the PE firm's risk tolerance is much different from a small practice's. In my experience, it is one of the sore spots I see most often. Private equity firms definitely evaluate risk differently, and they want the control.

Sacopulos: Is that negotiable, or is it fairly non-negotiable — just something you have to live with as a physician?

Schaefer: I think everything is negotiable with the right attorney. But there are some things they are pretty firm on, and I have seen it go both ways.

Sacopulos: Physicians have built their practices. They have got patient relationships, clinical autonomy, community involvement, and reputation. What are the non-negotiables these physicians need to address contractually before they sign off on a deal? And in your experience, what do physicians most often wish they had negotiated for that they missed? This is the seller's remorse question, Greg.

Schaefer: For a physician, the remorse comes from the fact that they are selling their practice so they can be a physician and not a business owner anymore. They love what they do. They have trained to take care of people and to have their patients. So most of the time, the remorse is about control and culture. As long as they understand that things are going to change — and that they can still be a doctor and see their patients — they seem happy. Where I see owners squeeze doctors to see more patients, in less time, with less staff, those are the pain points that really frustrate doctors. It affects bedside manner, and it affects the relationship between corporate and medical. But the real remorse, I think, comes from private equity deals that close with an equity component that was not what the physicians thought it was. That is the most important thing people don't spend enough time understanding before closing: What type of shares do I have, and when are they triggered? What happens if I retire? What happens if I quit? What happens if I get fired? Those are really important questions you need to understand.

Sacopulos: How long does the process take, from initiating a conversation with a PE firm to closing? I know it varies, but what is the minimum amount of time one should expect?

Schaefer: It depends on the size of the practice being acquired. The shortest I have seen is 120 days. On average, I would say the courting process is 9 to 12 months. But preparing before you go out to be courted should take at least a year to get everything organized. Then all your information gets loaded into a data room, and the process begins. The buyers vet all your information, come back with questions, and work with your advisors. There is also a cost to putting yourself out there that people need to understand. This takes time to close, and you have to pay your attorney, your insurance broker, and your accountant to help you with all these items.

Sacopulos: Let us just say that one more time: People have to pay their insurance broker and their attorney. Is that correct, Greg?

Schaefer: Yes — and on time.

Sacopulos: But the bigger message in what you just said is that this can be a multiyear process — preparing for it and then going through it to closing. It is not something you can do quickly. Is that fair?

Schaefer: That is fair. It is usually not a quick process. Private equity firms, although nimble, are very educated in their decisions, and a lot of analytics goes into them. And even post-close, you cannot just wash your hands of it and be done. There is a transition period, and a lot of documents need to come through. Speaking to insurance, there is often a transition to a new broker. Not all lines of business get switched over right away. There are named-insured issues that need to be addressed, and broker-of-record letters. So there is a lot of communication that goes on behind the scenes post-close.

Sacopulos: When a private equity firm consolidates practices under a single ownership umbrella, how does the risk profile change for malpractice, employment liability, cyber, general operations, and so on? And are PE-backed groups typically getting the insurance right?

Schaefer: We represent both private equity firms and medical practices, so I need to be careful here. But I think that is an advantage, because we sit on both sides of the table in these transactions. I do see PE firms get this wrong. Generally, it is the smaller ones trying to break into the healthcare sector. Some of those situations have been really good for us, because we have been able to win them as clients once they see this is our niche. One place I see issues quite frequently is ownership — understanding what ownership actually means. You have management services organizations, or MSOs, acquiring professional corporations or physician groups that only a physician can own. If the private equity firm doesn't have a physician, how do you make that happen? They create an MSO agreement to establish the ownership structure. Some insurance carriers say you have to own 51% or more of both entities to have them on the same insurance policy. In situations like that, there may be manuscript endorsements, and you need to work with a national carrier that understands this space: "We have a private equity firm that owns a physician group, and we cannot put them together. How do we overcome that?" A small practice is not going to be familiar with these issues, and some private equity firms are not either. Then there's malpractice, control, consent, and tail coverage. Some private equity firms trust local brokers who are generalists and are not familiar with this specific space. The larger firms that have done rollups across the country are really efficient, and it makes perfect sense: Someone who buys $5 million of med-mal insurance from one carrier is going to have much more leverage and negotiating power than you spending $500,000 a year on med mal. It is just a fact.

Sacopulos: Are the larger PE firms using captive insurance companies, at least for the initial layer of risk?

Schaefer: Yes, they are using captives, and that is really relevant to this conversation. With dermatology, ENT, and other single-specialty rollups — where physicians don't need to go into the hospital to see patients — captives are very useful. You can really hone in on training and risk management and make it very efficient. It is another tool for the private equity world to save money, lower the cost of insurance, and keep control. You can see the future a lot better, because you are not dependent on carriers' costs rising or falling. It is a really nice tool these days, and it is very easy on transactions post-close. Moving practices into the captive is quick and efficient.

Sacopulos: Does your firm provide guidance on risk issues to individuals or practices during the PE process?

Schaefer: Yes. We are usually brought in to look at the transaction when the data room opens. We take a snapshot of everything, put it into one document, and point out anything we might be concerned about in the transition process. We also assist private equity firms with risk retention groups and with preparing for their acquisitions.

Sacopulos: So, one more time: If I were a physician selling my dermatology practice, at what point in the process would it be appropriate for me to call you and say I could use some assistance?

Schaefer: Before the transaction. It is the same timing as engaging your attorney and your accountant. If you have all three from the beginning, it makes life much easier. Still, everybody finds something they maybe should have done a little better. Hindsight is 20/20, and none of us is perfect. But it helps to have somebody like you in your corner. You are an expert. You probably know very good insurance brokers you have worked with, and you have done closings with accountants who are really sharp and understand the space. It ends up saving you money, it speeds things up, and communication is much easier.

Sacopulos: Excellent. As our time draws to an end, I want to shift gears to something you have started that I find really interesting. I was hoping you could take a few minutes to tell me about the Forward Motion Fund.

Schaefer: Thank you, I appreciate that. I was diagnosed with Parkinson's disease in 2023. It was a shock — I was under 50 at the time — and it changed my life. I have a new perspective on everything. I am trying to move forward, put that diagnosis behind me, and live my new life as best I can. My wife and I were fortunate enough to start the Forward Motion Fund, a 501(c)(3) nonprofit that will donate money to Parkinson's research. Unfortunately, there is no cure. I would say the leader in our space is Michael J. Fox, who has done an incredible job; his foundation has raised over $2 billion for research. We are trying to do our part to bring awareness. ForwardMotionFund.org is the charity we started, and you can find more information at GregorySchaefer.com. Our social media handle is unique: It is GSchaeferUndefined. It started when Ironman did a video about me finishing my 18th Ironman event, and it runs in unison with the Forward Motion Fund. So take a look — it is GSchaeferUndefined if you would like to follow.

Sacopulos: That is phenomenal. You are doing good work. Eighteen Ironman competitions — very impressive, Greg. You really make the rest of us feel like we have accomplished so little. But in all seriousness, well done, and I wish you great success with ForwardMotionFund.org. I encourage audience members to check it out and support it. What a great cause. Greg Schaefer, thank you for all the tremendous information. If people would like to reach out to you, how can they best get hold of you?

Schaefer: Sure. My email is greg@seinewyork.com. I am with Patriot Growth Insurance Services. All my information, including my cell phone number, is also on GregorySchaefer.com — and I still pick up every call.

Sacopulos: Excellent. Greg Schaefer, thank you so much for being on SoundPractice.

Schaefer: Thank you so much.

Resources

Listen to this episode of SoundPractice.

TopicsPayment ModelsEnvironmental InfluencesHealth Law